ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 21 filers reported holding ANI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $71,000 | +9.2% | 59,000 | 0.0% | 0.00% | – |
| Q1 2019 | $65,000 | +10.2% | 59,000 | 0.0% | 0.00% | – |
| Q4 2018 | $59,000 | -95.6% | 59,000 | -95.1% | 0.00% | -100.0% |
| Q2 2018 | $1,348,000 | +1606.3% | 1,195,000 | +1559.7% | 0.00% | – |
| Q1 2018 | $79,000 | +139.4% | 72,000 | +132.3% | 0.00% | – |
| Q2 2017 | $33,000 | -92.1% | 31,000 | -91.5% | 0.00% | – |
| Q4 2016 | $417,000 | – | 363,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 9,000,000 | $10,149,000 | 12.63% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,751,000 | $33,847,000 | 2.02% |
| Wellesley Asset Management | 25,925 | $29,366,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,455,000 | 1.38% |
| Perceptive Advisors | 7,500,000 | $8,458,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,857,000 | $7,767,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,975,000 | $6,769,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,718,000 | $1,945,000 | 0.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 930,000 | $1,049,000 | 0.03% |
| GABELLI FUNDS LLC | 1,750,000 | $1,983,000 | 0.01% |